Behavior therapy for children with tourette disorder: A randomized controlled trial

JAMA

Volumn 303, Issue 19, 2010, Pages 1929-1937

  Piacentini, John ^a   Woods, Douglas W ^b   Scahill, Lawrence ^c   Wilhelm, Sabine ^d   Peterson, Alan L ^e   Chang, Susanna ^a   Ginsburg, Golda S ^f   Deckersbach, Thilo ^d   Dziura, James ^c   Levi Pearl, Sue ^g   Walkup, John T ^f,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f DEPARTMENT OF PATHOLOGY   (United States)

^g Tourette Syndrome Association   (United States)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZODIAZEPINE; CLONAZEPAM; CLONIDINE; DONEPEZIL; ETIRACETAM; GUANFACINE; HALOPERIDOL; OLANZAPINE; PIMOZIDE; RISPERIDONE; VALPROIC ACID;

ADOLESCENT; ADOLESCENT DISEASE; ARTHRALGIA; ARTICLE; BEHAVIOR THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONCUSSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DISRUPTIVE BEHAVIOR; FATIGUE; FEMALE; FRACTURE; GILLES DE LA TOURETTE SYNDROME; HABIT REVERSAL TRAINING; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MYALGIA; NAUSEA; NECK INJURY; NECK PAIN; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RASH; SCHOOL CHILD; SCORING SYSTEM; SINGLE BLIND PROCEDURE; SORE THROAT; SPORT INJURY; STOMACH DISCOMFORT; SUNBURN; THERAPY EFFECT; TRAINING; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 77952389110     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.607     Document Type: Article

References (49)

1. Khalifa N, von Knorring A. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol. 2003;45(5):315-319.
2. Centers for Disease Control and Prevention (CDC). Prevalence of diagnosed Tourette syndrome in persons aged 6-17 years-United States, 2007. MMWR Morb Mortal Wkly Rep. 2009;58(21):581-585.
3. Leckman JF, Bloch MH, King RA, Scahill L. Phenomenology of tics and natural history of tic disorders. In: Walkup JT, Mink JW, Hollenbeck PJ, eds. Advances in Neurology: Tourette Syndrome. Vol 99. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:1-16.
4. Woods D, Marcks B, Flessner C. Management of social and occupational difficulties in persons with Tourette syndrome. In: Woods D, Piacentini J, Walkup JT, eds. Treating Tourette Syndrome and Tic Disorders. New York, NY: Guilford Press; 2007:265-278.
5. Leckman JF, Walker DE, Cohen DJ. Premonitory urges in Tourette's syndrome. Am J Psychiatry. 1993;150(1):98-102.
6. Jankovic J. Tourette's syndrome. N Engl J Med. 2001;345(16):1184-1192.
7. Scahill L, Erenberg G, Berlin C, et al. Contemporary assessment and pharmacotherapy of Tourette syndrome (2006). NeuroRx. 2006;3(2):192-206.
8. Cook C, Blacher J. Evidence-based psychosocial treatments for tic disorders. Clin Psychol Sci Prac. 2007;14:252-267.
9. Evers RA, Van De Wetering B. A treatment model for motor tics based on a specific tension reduction technique. J Behav Ther Exp Psychiatry. 1994;25(3):255-260.
10. Miguel EC, Coffey BJ, Baer L, Savage CR, Rauch SL, Jenike MA. Phenomenology of intentional repetitive behaviors in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry. 1995;56(6):246-255.
11. Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette's syndrome: a review. J Psychosom Res. 2008;65(5):487-496.
12. Woods DW, Piacentini JC, Chang S, et al. Managing Tourette's Syndrome: A Behavioral Intervention for Children and Adults. New York, NY: Oxford University Press; 2008.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
14. Leckman JF, Riddle MA, Hardin MT, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28(4):566-573.
15. Peterson A. Psychosocial management of tics and intentional repetitive behaviors associated with Tourette syndrome. In: Woods DW, Piacentini JC, Walkup JT, eds. Treating Tourette Syndrome and Tic Disorders: A Guide for Practitioners. New York, NY: Guilford Press; 2007:154-184.
16. Hanley GP, Iwata B, McCord B. Functional analysis of problem behavior: a review. J Appl Behav Anal. 2003;36(2):147-185.
17. Watson TS, Dufrene B, Weaver A, Butler T, Meeks C. Brief antecedent assessment and treatment of tics in the general education classroom. Behav Modif. 2005;29(6):839-857.
18. Goetz C, Horn S. The treatment of tics. In: Kurlan R, ed. Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. 2nd ed. New York, NY: Marcel Dekker; 2005:411-426.
19. Wilhelm S, Deckersbach T, Coffey BJ, Bohne A, Peterson AL, Baer L. Habit reversal versus supportive psychotherapy for Tourette's disorder: a randomized controlled trial. Am J Psychiatry. 2003;160(6):1175-1177.
20. Albano AM, Silverman WK. The Anxiety Disorders Interview Schedule for DSM-IV, Child Version: Clinician Manual. New York, NY: Oxford University Press; 1996.
21. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753-2766.
22. Guy W, Bonato R, eds. CGI: Clinical Global Impressions. Chevy Chase, MD: National Institute of Mental Health; 1970.
23. Shaffer D, Gould MS, Brasic J, et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231.
24. Chang S, Himle M, Tucker B, Woods D, Piacentini J. Initial psychometric properties of a brief parent-report instrument for assessing tic severity in children with chronic tic disorders. Child Fam Behav Ther. 2009;31(3):181-191.
25. Scahill L, Leckman J, Schultz R, Katsovich L, Peterson B. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology. 2003;60(7):1130-1135.
26. Jankovic J, Jimenez-Shahed J, Brown LW. A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010;81(1):70-73.
27. Sallee FR, Kurlan R, Goetz CG, et al. Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry. 2000;39(3):292-299.
28. Borenstein M, Rothstein H, Cohen J. Power and Precision. Teaneck, NJ: Biostat; 1997.
29. Carpenter JR, Kenward MG. Missing Data in Randomised Controlled Trials: A Practical Guide. Birmingham, AL: National Institute for Health Research; 2008. http://www.pcpoh.bham.ac.uk/publichealth/methodology/projects/RM03-JH17-MK. shtml. Publication RM03/JH17/MK.
30. Allison PD. Missing Data: University Papers Series on Quantitative Applications in the Social Sciences. Thousand Oaks, CA: Sage; 2001.
31. Brown H, Prescott R. Applied Mixed Models in Medicine. Chichester, England: John Wiley & Sons; 1999.
32. Samsa G, Edelman D, Rothman ML, Williams GR, Lipscomb J, Matchar D. Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics. 1999;15(2):141-155. (Pubitemid 29093257)
33. Himle MB, Woods DW, Piacentini JC, Walkup J. Brief review of habit reversal training for Tourette's syndrome. J Child Neurol. 2006;21(8):719-725. (Pubitemid 44295132)
34. Swanson JM, Kraemer HC, Hinshaw SP, et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry. 2001;40(2):168-179.
35. McCracken JT, McGough J, Shah B, et al; Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347(5):314-321.
36. Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969-1976.
37. Gilbert DL, Buncher CR. Assessment of scientific and ethical issues in two randomized clinical trial designs for patients with Tourette's syndrome: a model for studies of multiple neuropsychiatric diagnoses. J Neuropsychiatry Clin Neurosci. 2005;17(3):324-332.
38. Burd L, Kerbeshian J. Treatment-generated problems associated with behavior modification in Tourette disorder. Dev Med Child Neurol. 1987;29(6):831-833.
39. Gaffney GR, Perry PJ, Lund BC, Bever-Stille KA, Arndt S, Kuperman S. Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 2002;41(3):330-336. (Pubitemid 38338155)
40. Gilbert DL, Batterson JR, Sethuraman G, Sallee FR. Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial. J Am Acad Child Adolesc Psychiatry. 2004;43(2):206-214.
41. Ross MS, Moldofsky H. Comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette syndrome. Am J Psychiatry. 1978;135(5):585-587. (Pubitemid 8329032)
42. Kushner HA. Cursing Brain? The Histories of Tourette Syndrome. Cambridge, MA: Harvard University Press; 1999.
43. Stevens J, Blachly H. Successful treatment of the maladie des tics in Gilles de la Tourette's syndrome. Am J Dis Child. 1966;112(6):541-545.
44. Baym CL, Corbett BA,Wright SB, Bunge SA. Neural correlates of tic severity and cognitive control in children with Tourette syndrome. Brain. 2008;131(pt 1):165-179.
45. Church JA, Fair DA, Dosenbach NUF, et al. Control networks in paediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain. 2009;132(1):225-238.
46. Marsh R, Maia TV, Peterson BS. Functional disturbances within frontostriatal circuits across multiple childhood psychopathologies. Am J Psychiatry. 2009;166(6):664-674.
47. Graybiel A, Canales J. The neurobiology of repetitive behaviors: clues to the neurobiology of Tourette syndrome. In: Cohen DJ, Jankovic J, Goetz C, eds. Advances in Neurology: Tourette Syndrome. Vol 99. Philadelphia, PA: Lippincott Williams & Wilkins; 2001:123-132.
48. Kalanithi PSA, Zheng W, Kataoka Y, et al. Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome Proc Natl Acad Sci U S A. 2005;102(37):13307-13312. (Pubitemid 41325019)
49. Mink JW. Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. In: Walkup JT, Mink JW, Hollenbeck PJ, eds. Advances in Neurology: Tourette Syndrome. Vol 99. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:89-98.